Doctor profile · Federal record

Dr. Emily Neely, MD

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Nashville, TN

  • NPI 1598812455
  • Accepts Medicare
  • MIPS 98.0 / 100 · 2023
  • 20 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
330 23Rd Ave N Ste 500
Nashville, TN 37203
(615) 342-5900
fax (615) 342-7864
Additional location
4230 Harding Pike, Suite 527
Nashville, TN 372052013
(615) 386-3067
fax (615) 385-0612

Credentials & registration

NPPES · NUCC
NPI registered
January 2007 — 19 yrs on file
Profile last updated
November 22, 2019
Year of graduation
2006 — 20 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Tennessee #47619
Medicaid
TN #3710089

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1598812455. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,349
Distinct HCPCS
7
Medicare allowed
$122,518
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 2,580 24 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 430 225 $120
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 130 53 $33
82962 Blood glucose (sugar) test performed by hand-held instrument 102 56 $3
96372 Injection of drug or substance under skin or into muscle 59 28 $13
99204 New patient office or other outpatient visit, 45-59 minutes 24 24 $156
99213 Established patient office or other outpatient visit, 20-29 minutes 24 15 $85

In context: peer comparison

Among 16 peers in this city , average services per provider: 277. This provider delivers 12× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,159
Transactions
137
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novo Nordisk Inc 26 $581.23
Lilly USA, LLC 22 $428.88
Abbott Laboratories 17 $294.58
Amgen Inc. 13 $229.02
ABBVIE INC. 9 $183.87
Xeris Pharmaceuticals, Inc. 9 $169.53
Boehringer Ingelheim Pharmaceuticals, Inc. 9 $149.83
CeQur Corporation 1 $146.29
SANOFI-AVENTIS U.S. LLC 7 $138.25
Tandem Diabetes Care, Inc. 5 $130.42
BETA BIONICS, INC. 5 $108.01
Antares Pharma, Inc. 4 $74.17
Corcept Therapeutics 3 $73.06
Amphastar Pharmaceuticals, Inc. 4 $71.55
Medtronic, Inc. 3 $50.05

By nature of payment

Food and Beverage
$3,159

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,339
Patients
377
Total drug cost
$714,535
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 269 73 $4,526
Ozempic (Semaglutide) Brand 140 36 $227,336
Metformin Hcl Er (Metformin Hcl) Brand 123 38 $1,873
Tresiba Flextouch U-100 (Insulin Degludec) Brand 100 28 $65,897
Glipizide Generic 92 25 $1,322
Synthroid (Levothyroxine Sodium) Brand 89 24 $9,084
Metformin Hcl Generic 77 25 $882
Mounjaro (Tirzepatide) Brand 72 14 $90,465
Soliqua 100-33 (Insulin Glargine/Lixisenatide) Brand 66 17 $101,737
Alendronate Sodium Generic 58 18 $807

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Emily Neely's medical specialty?
Dr. Emily Neely practices Endocrinology, Diabetes & Metabolism Physician in Nashville, TN.
Where does Dr. Emily Neely practice?
Dr. Emily Neely practices at 330 23Rd Ave N Ste 500, Nashville, TN 37203. Office phone: 6153425900.
What is Dr. Emily Neely's NPI?
Dr. Emily Neely's National Provider Identifier (NPI) is 1598812455, issued by NPPES.
Does Dr. Emily Neely accept Medicare assignment?
Yes. Dr. Emily Neely accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Emily Neely commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.